about
Equillium Inc is a biotechnology innovator developing novel therapies to treat severe autoimmune and inflammatory disorders with the mission to develop life-changing therapeutics for patients. It primary goal is to advance EQ504, a novel aryl hydroca...
Read More
2.19
-0.06
(-2.67%)
7,645.5
XNAS Volume
XNAS 12 May, 2026 9:58 AM (EDT)
Board Meeting
The next board meeting for Equillium Inc is on 21 May 2026 for the purpose of Equillium Inc Annual General Meeting for 2026
See details
Not Eligible
Expensive Valuation
Technically Bullish
Equillium Inc Live Price Chart
Switch to TradingView
Loading Fundamental data..
Loading data..